A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We deliver transformative solutions that power real results. See how we can help.
Optimizing Supply Chain
Maximizing Value-Based Care
Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.
At every level of leadership, Premier’s experts are driving healthcare forward.
Board of Directors
Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.
Find Out How
Collective purchasing power lowers costs across your organization.
Intelligence plus unparalleled analytics equals data-driven solutions.
It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.
Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.
A voice for better healthcare policy is a voice for you.
Working closely with our members, we’re developing products and services to solve your most complex challenges.
Lower costs, greater efficiencies and a healthier bottom line.
Proven practices that result in better outcomes.
Intersecting specialty drugs with better management and data-driven best practices.
Controlling your future with integrated care delivery practices.
More savings and ROI is a win-win.
Data diving to deliver insights you can act on.
Data, inquiry and intervention services.
Our most recent insights, articles and more, all in one place.
View Our Latest
Discover what leading healthcare providers are achieving through Premier membership.
Stay informed with our white papers, webinars and e-books.
Browse our blog for a taste of what’s new and what’s next in healthcare.
Premier’s perspectives have been solicited by nationally renowned publications. Read on.
Read Premier’s latest announcements.
Catch our policy statements and perspectives on the latest in DC.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
Soumi Saha, Premier’s Senior Director of Advocacy, is providing comments on how Premier is implementing and measuring improvement efforts in the fight against AMR.
Becker's Hospital Review |
Premier’s Daisy Jackson sat down with Jon Faldasz, head of clinical applications for InsightRX, to discuss all things precision dosing.
Premier offered evidence-based policy recommendations to help Congress develop the next generation of the 21st Century Cures Act.
The reality in emergency rooms across the country is that life-saving drugs vital to patient care just aren’t available.
It’s essential for providers to be ready at any time for surveyors, especially now that the new USP 800 hazardous drugs regulations are in effect.
Michael Alkire, President of Premier Inc., talks about drug shortages with Lisa Abramowicz and Paul Sweeney.
Integrated solution aims to decrease serious side effects caused by vancomycin and other antibiotics used to treat infectious diseases
Premier and 47 national trade associations, health systems and hospitals, pharmacy associations, and small businesses voiced support for the MEDS Act.
Premier underscored how drug shortages threaten the security of the pharmaceutical supply chain.
Premier strongly supports the MEDS Act (S. 2723), introduced today by Senators Susan Collins (R-ME) and Tina Smith (D-MN).
We hear that major legislation may be introduced this week to address drug shortages.
Premier Statement on the FDA Drug Shortage Task Force report.
Thanks to ProvideGx, the multi-year, national shortage of cysteine hydrochloride injection has been successfully resolved.
Premier submitted comments cautioning the DEA to carefully consider how a reduction in manufacturing quotas for certain opioids could rekindle recent drug shortages.
Through its ProvideGx™ program, Premier has partnered with Amphastar Pharmaceuticals, Inc. to supply to healthcare providers phytonadione injection and emergency, pre-filled syringes.
Premier's ProvideGx™ program and its partnership with Exela Pharma Sciences has successfully resolved the multi-year, national shortage of cysteine hydrochloride injection.
InsightRx, a precision medicine company announced the closing of funding with participation from several organizations including Premier.
Members of Premier applaud the FDA for finalizing guidance on the use of citizen petitions to delay the market entry of generic medications and biosimilars.
Premier submitted comments to CMS on its proposed rule aiming to reduce burden and redundant requirements in long-term care facilities (LTCFs). In its comments...
Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies.
Premier continues to urge CMS to amend its misguided policy for Medicare coverage of home infusion therapy services.